Free Access: Please Log In
This content is completely free—but you need to be logged in to read the full article. If you already have an account, please log in below. Otherwise, register for free to unlock instant access.
References (16)
- Melmed S, Casanueva FF, Hoffman AR, et al; Endocrine Society. Diagnosis and treatment of hyperprolactinemia: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(2):273–288. PubMed CrossRef
- Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30(2):239–245. PubMed CrossRef
- Simpson GM, Angus JW. A rating scale for extrapyramidal side effects. Acta Psychiatr Scand suppl. 1970;45;(S212):11–19. PubMed CrossRef
- Inder WJ, Castle D. Antipsychotic-induced hyperprolactinemia. Aust N Z J Psychiatry. 2011;45(10):830–837. PubMed CrossRef
- Zhu Y, Zhang C, Siafis S, et al. Prolactin levels influenced by antipsychotic drugs in schizophrenia: a systematic review and network meta-analysis. Schizophr Res. 2021;237:20–25. PubMed CrossRef
- Vilar L, Vilar CF, Lyra R, et al. Pitfalls in the diagnostic evaluation of hyperprolactinemia. Neuroendocrinology. 2019;109(1):7–19. PubMed CrossRef
- Andrade C. Low-dose amisulpride and elevation in serum prolactin. J Clin Psychiatry. 2013;74(6):e558–e560. PubMed CrossRef
- Kapur S, Langlois X, Vinken P, et al. The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats. J Pharmacol Exp Ther. 2002;302(3):1129–1134. PubMed CrossRef
- El-Mallakh RS, Watkins J. Prolactin elevations and the permeability glycoprotein. Prim Care Companion CNS Disord. 2019;21(3):18nr02412.https. PubMed CrossRef
- Holt RIG, Peveler RC. Antipsychotics and hyperprolactinaemia: mechanisms, consequences and management. Clin Endocrinol (Oxf). 2011;74(2):141–147. PubMed CrossRef
- Lee BH, Kang SG, Kim TW, et al. Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients. Psychiatry Clin Neurosci. 2012;66(1):69–73. PubMed CrossRef
- Raj R, Sidhu BS. Hyperprolactinemia with amisulpride. Indian J Psychiatry. 2008;50(1):54–56. PubMed CrossRef
- Kopecek M, Bares M, Svarc J, et al. Hyperprolactinemia after low dose of amisulpride. Neuroendocrinol Lett. 2004;25(6):419–422. PubMed
- Glatard A, Guidi M, Delacrétaz A, et al. Amisulpride: real-world evidence of dose adaptation and effect on prolactin concentrations and body weight gain by pharmacokinetic/pharmacodynamic analyses. Clin Pharmacokinet. 2020;59(3):371–382. PubMed CrossRef
- Zhang L, Qi H, Xie YY, et al. Efficacy and safety of adjunctive aripiprazole, metformin, and paeoniae-glycyrrhiza decoction for antipsychotic-induced hyperprolactinemia: a network meta-analysis of randomized controlled trials. Front Psychiatry. 2021;12:728204. PubMed CrossRef
- Chen CK, Huang YS, Ree SC, et al. Differential add-on effects of aripiprazole in resolving hyperprolactinemia induced by risperidone in comparison to benzamide antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34(8):1495–1499. PubMed CrossRef
Please sign in or purchase this PDF for $40.